Top Markets
Coin of the day
AroCell AB (publ) AroCell AB (publ)

AroCell AB (publ)

AROC
Rank in Stocks #31795
AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on... AroCell AB (publ) is an in vitro diagnostics enterprise primarily focused on the surveillance of various cancerous conditions, such as hematological malignancies, breast cancer, and other solid tumors. The company develops, produces, and markets its flagship product, AroCell TK 210 ELISA, an immunoassay kit designed for measuring Thymidine Kinase 1 levels in human blood. Additionally, AroCell provides TUBEX TF, a rapid bacteriological test for the detection of typhoid fever. Founded in 2000, the firm was originally known as Xi Bao Research AB, adopting its current name, AroCell AB (publ), in 2006. It maintains its headquarters in Uppsala, Sweden.
Share Price
$0.05234265
Last synced: 2025-06-23
Market Cap
$12.06M
Change (1 day)
-3.01%
Change (1 year)
0.00%
Country
SE
Trade AroCell AB (publ) (AROC)

Category

P/B ratio for AroCell AB (publ) (AROC)
P/B ratio as of 2026 TTM: 0
According to AroCell AB (publ) latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for AroCell AB (publ) from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
27.366 -
US